Working to improve the communication of important drug safety information about generic drugs Posted on November 8, 2013 by FDA Voice By: Janet Woodcock, M.D.

FDA is taking a step today that is intended to improve the communication of important drug safety information about generic drugs to both prescribers and patients. 

All drug manufacturers are required to keep close tabs on their drugs once they go to market, reviewing all reports of adverse events involving their drug and reporting these findings to FDA. 

- See more at: http://blogs.fda.gov/fdavoice/index.php/2013/11/working-to-improve-the-communication-of-important-drug-safety-information-about-generic-drugs/?source=govdelivery&utm_medium=email&utm_source=govdelivery#sthash.yiFApCCt.dpuf